Select your body :
Remit
The Scientific Advisory Board gives its opinion on the major orientations of our agency’s scientific strategy and on its activities. It also provides a forward-looking approach and reports on the work undertaken. This body helps to coordinate the efforts of its members in preparing for and responding to crises linked to emerging diseases, at scientific, industrial and public action levels.
It brings together 21 French and international scientific figures, as well as three representatives from the voluntary sector. Members are appointed for a four-year term by the Advisory Board on the recommendation of the agency Director.
Chair
Prof. Sharon Lewin
University of Melbourne, The Doherty Institute, Australia
Members
Fareed Abdullah
(South African Medical Research Council, Steve Biko Academic Hospital, South African TB Think Tank, South Africa)
Dominique Costagliola
(Member of the Academy of Sciences, Emeritus Research Director, Inserm, Pierre Louis Institute of Epidemiology and Public Health, France.)
Veronique Deret
(SOS Hépatites, France )
Meg Doherty
(World Health Organization, Switzerland)
Daniel Douek
(Vaccine Research Center, NIAID/NIH, United States)
Diana Finzi
(Division of AIDS NIAID/NIH, United States)
Hugues Fischer
(TRT5-Act-up, France )
Peter Horby
(Pandemic Sciences Centre, ISARIC, United Kingdom)
Brad Jones
(Weill Cornell Medical College, United States)
Marion Koopmans
(Erasmus MC, Netherlands)
Gabriel Leung
(Hong Kong University, Hong-Kong )
Seng Gee Lim
(National University Health System, Singapore)
Jennifer Price
(University of California San Francisco UCSF Health, United States)
Ester Sabino
(Universidade de São Paulo, Brasil)
Rodolphe Thiebaut
(Bordeaux Population Health – Inserm Unit 1219, Bordeaux University Hospital, University of Bordeaux, France)
Robert Thimme
(Medical Center – University of Freiburg, Germany)
Lucas Vallet
(TRT5-CHV, France)
Sylvie van der Werf
(Institut Pasteur, Université de Paris, France)
Scott C. Weaver
(University of Texas Medical Branch, Galveston National Laboratory, Etats-Unis)
Fabien Zoulim
(Hospices Civils de Lyon, Inserm Unité 1052, Centre de recherche en cancérologie de Lyon, France )